Sysmex (OTCMKTS:SSMXY) Posts Earnings Results

Sysmex (OTCMKTS:SSMXY) announced its quarterly earnings data on Wednesday. The company reported $0.17 EPS for the quarter, Zacks reports. Sysmex updated its FY 2024 guidance to 0.580-0.580 EPS.

Sysmex Price Performance

Shares of SSMXY opened at $18.22 on Wednesday. The company has a market cap of $11.47 billion, a price-to-earnings ratio of 36.91 and a beta of 0.90. Sysmex has a 1-year low of $14.38 and a 1-year high of $28.58. The company’s fifty day simple moving average is $18.92 and its 200 day simple moving average is $19.02. The company has a current ratio of 3.19, a quick ratio of 2.42 and a debt-to-equity ratio of 0.11.

Sysmex Company Profile

Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.